fda warning letter hims & hers compounded semaglutide september 2025 and Novo Nordisk Warn of GLP-1 Telehealth Compounding Take Down – What's Next? FDA and Novo Nordisk Warned
Description
Yet thanks to the medications effect on heart health and weight, semaglutide may impact blood pressure too
Proud to have helped bring this to market
Zuranolone (Zurzuvae, Biogen) has been approved by the MHRA to treat postnatal depression
Liraglutide was the first widely adopted GLP-1 agonist, though it requires daily rather than weekly dosing
Iilun Murphy, the director of the Office of Generic Drugs in the FDAs Center for Drug Evaluation and Research, said in a statement
